Hepatocyte PLAGL2 deficiency alleviates MASH through MYD88-licensed inactivation of inflammasome
{{output}}
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a pressing global health concern. The transition to metabolic dysfunction-associated steatohepatitis (MASH) is characterized by pyroptosis-driven inflammation. However, the spatiotemporal regu... ...